Hepatitis C virus experimental model systems and antiviral drug research.
about
Passive immune neutralization strategies for prevention and control of influenza A infections.Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type CIdentification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assayPermissiveness of human hepatoma cell lines for HCV infection.Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents.
P2860
Hepatitis C virus experimental model systems and antiviral drug research.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis C virus experimental model systems and antiviral drug research.
@ast
Hepatitis C virus experimental model systems and antiviral drug research.
@en
Hepatitis C virus experimental model systems and antiviral drug research.
@nl
type
label
Hepatitis C virus experimental model systems and antiviral drug research.
@ast
Hepatitis C virus experimental model systems and antiviral drug research.
@en
Hepatitis C virus experimental model systems and antiviral drug research.
@nl
prefLabel
Hepatitis C virus experimental model systems and antiviral drug research.
@ast
Hepatitis C virus experimental model systems and antiviral drug research.
@en
Hepatitis C virus experimental model systems and antiviral drug research.
@nl
P2860
P1433
P1476
Hepatitis C virus experimental model systems and antiviral drug research.
@en
P2093
Susan L Uprichard
P2860
P2888
P304
P356
10.1007/S12250-010-3134-0
P577
2010-07-28T00:00:00Z
P5875
P6179
1013304825